Kane Biotech Announces Positive Efficacy Results in STEM Pet Oral Care Clinical Trial
March 10, 2021 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, March 10, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane”), announced today that preliminary analysis of data from efficacy trials...
Kane Biotech Announces New Chairman
February 24, 2021 08:45 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), announced today current Board member Mark Nawacki will take over...
Kane Biotech Announces Launch of New Human Health OTC DermaKB™ Product Line
December 10, 2020 08:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Biotech Announces Third Quarter 2020 Financial Results
November 26, 2020 17:31 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 26, 2020 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Biotech to Release Third Quarter 2020 Financial Results on November 26 – Conference Call to Follow
November 19, 2020 17:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Biotech Enters into Credit Facility with Pivot Financial
November 05, 2020 17:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane Biotech”) today announced that it has entered into a one year credit agreement (the “Credit...
Kane Biotech builds upon successful results with launch of a US Consumer Test
October 28, 2020 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane Biotech,” or “the Company”) is pleased to announce that the launch of a larger consumer...
STEM Animal Health Appoints New President and CEO
October 13, 2020 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane Biotech”) today announced that Kevin Cole will assume the role of President and CEO of STEM...
Kane Biotech and Animalcare to Form Animal Health Company to Target Biofilm-Related Ailments
September 28, 2020 09:45 ET
|
Kane Biotech Inc.
Animalcare to Invest $5 million, Consisting of $3 million to Acquire One-Third Stake in STEM Animal Health, Kane Biotech’s New Animal Health Subsidiary, and $2 million for Rights to Commercialize...
Kane Biotech Appoints New Advisor
September 23, 2020 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Sept. 23, 2020 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Company,” “Kane Biotech”) today announced that it has entered into an agreement with Harbor Access...